PATENT CLAIM ANALYSIS

Application Number: 15909677
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["422", "500000"]

Abstract:
A microfluidic, chip-based assay device has been developed for measuring physical properties of an analyte (particularly, whole blood or whole blood derivatives). The technologies can be applied to measure clotting times of whole blood or blood derivatives, determine the effects of anticoagulant drugs on the kinetics of clotting/coagulation, as well as evaluate the effect of anticoagulant reversal agents. These technologies can additionally be used to optimize the dosage of anticoagulation drugs and/or their reversal agents. The assay is independent of the presence of anticoagulant; clotting is activated by exposure of the blood sample in the device to a glass (or other negatively charged material such as oxidized silicon) surface, which activates the intrinsic pathway and can be further hastened by the application of shear flow across the activating materials surface. The absence of chemical activating agents and highly controlled and reproducible micro-environment yields a point of care universal clotting assay.

Claim (Index 17):
The test microchip of  claim 15  further comprising a temperature controlling element.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 90.0
- Lexical Diversity: 1.70103
- Patent Class: 422.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14849348', '10168473', '15879714', '14866266', '14866460']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7729670497817712
- 35 USC 102 Novelty (BERT): 0.5646994266897887
- Combined Prediction Score: 0.752140287472573
- Mean Citation Score: 303.444024
- Max Citation Score: 570.1271
- Similarity Product: 361.00369231110807

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test